Metraipolis › archive › dc_bf72b6d2d98f

Central Nervous System Activity of Lazertinib in EGFR-Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG-LU20-15 and LU21-01 — Europe PMC PMID:42670582

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42670582
DOI
10.1111/1759-7714.70387
License (as archived)
solo-consultazione
Archived
2026-10-07T22:58:05.008Z
SHA-256 of the archived text
445af841c445ffcf1586bb039816092bb635ddf40b38b4898fe2d74a2ac15636
Stable URL of this page
https://metraipolis.com/documento/dc_bf72b6d2d98f

How to cite

Central Nervous System Activity of Lazertinib in EGFR-Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG-LU20-15 and LU21-01 — Europe PMC PMID:42670582 — Europe PMC (en), https://europepmc.org/article/MED/42670582 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf72b6d2d98f (Metraipolis archive dc_bf72b6d2d98f, sha256 445af841c445ffcf1586bb039816092bb635ddf40b38b4898fe2d74a2ac15636)
BibTeX
@misc{dcbf72b6d2d98f,
  title = {Central Nervous System Activity of Lazertinib in EGFR-Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG-LU20-15 and LU21-01 — Europe PMC PMID:42670582},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42670582},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf72b6d2d98f; sha256 445af841c445ffcf1586bb039816092bb635ddf40b38b4898fe2d74a2ac15636},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42670582. Agents can read the archived copy with the MCP tool read_document.